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Background: Scabies is a common parasitic infection caused by the mite Sarcoptes Scabiei. About 300 million cases
of scabies are reported annually. Scabies usually presents clinically with an erythematous excoriated papulovesicular
rash, burrows, nodules and hyperkeratotic lesions in specific body areas.
A rare presentation of scabies is the bullous pemphigoid-like bullous scabies. So far, to the best of our knowledge,
only 32 cases of bullous scabies have been reported in medical literature, of which only 11 were under 60 years of
age at the time of initial presentation. This is the first case of bullous scabies being reported from Pakistan.
Case presentation: Herein we discuss, with reference to the existing literature, the case of a 23-year-old Punjabi
male who presented with a 3 day history of a tense, non-erythematous, non-tender bulla measuring approximately
0.5 cm x 0.8 cm on the right foot near the interdigital cleft. He was diagnosed to have bullous scabies.
Conclusion: The diagnosis of scabies should be considered in all patients who present with tense bullous lesions
accompanied by pruritus and a maculopapular rash. This is particularly relevant if these lesions do not resolve with
steroid treatment. In such patients, in order to prevent a misdiagnosis of bullous pemphigoid, scrapings for
Sarcoptes Scabiei mites and eggs should be taken.
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Scabies is a common parasitic infection caused by the
mite Sarcoptes Scabiei [1]. It spreads through human
contact; there are over 300 million cases of scabies re-
ported annually [2].
In adults, scabies presents as a small papulovesicular
rash with a clinical picture comprising of pruritus, pap-
ules and nodules associated with inflammation [3]. Sub-
cutaneous burrows are pathognomonic of the disease
and can have a widespread distribution including the
flexor surfaces of the wrists, lateral aspects of fingers,
elbows, anterior part of the axillary folds, the interdigital
web spaces, the belt line, the scrotum in males and the
areolar area of the breast in female patients [4]. The
most commonly affected areas in order of incidence are
the hands (86 %), wrist (82 %), genitalia of male patients* Correspondence: ameer.hamzasohail@gmail.com
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creativecommons.org/publicdomain/zero/1.0/(64.5 %), abdomen (56 %) and nipple area in females
(28 %) [5].
Patients with scabies can develop various secondary
lesions, such as folliculitis, eczema, pseudolymphoma
and impetigo. Atypical presentations of scabies include
urticarial rash, dermatitis herpetiformis and Darier’s
disease [1].
A rare subtype of scabies is bullous scabies which
occurs concurrently with, or after, the appearance of sca-
bietic lesions. It presents as bullous pemphigoid-like bul-
lae, and at times can even induce the formation of true
bullous pemphigoid lesions [6]. The first case of bullous
scabies was reported in 1974 by Bean et al. [7] and to
the best of our knowledge only 32 cases of bullous sca-
bies have been reported in medical literature so far
[1,4,8]. Out of these, only 11 were under the age of
60 years at the time of initial presentation [1,4,8].
Herein we report the case of a 23-year-old male who
presented with a bullous lesion on the right foot. He was
diagnosed to have bullous scabies.s article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Fig. 2 Shows another view of the same bulla
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A 23-year-old male belonging to the Punjabi ethnic
group presented with a 3 day history of a large, tense,
non-erythematous, non-tender blister on the right foot.
The patient also complained of lesions on the hands for
the preceding week. The lesions were pruritic (more so
at night) and there was no history of fever, trauma or
burns. The patient denied any history of unprotected
sexual contact. His past medical and surgical history was
unremarkable, as was his drug history. Family history
was positive for diabetes mellitus and asthma. He
had no known allergies, was a nonsmoker and did
not have any addictions. Review of systems was also
unremarkable.
On examination, the patient was hemodynamically
stable. Cutaneous examination revealed erythematous,
excoriated maculopapular lesions and burrows on the
wrists and the interdigital areas of both the hands. A
tense bulla measuring approximately 0.5 cm x 0.8 cm
was noted on the plantar surface of the right foot near
the interdigital cleft (Figs. 1 and 2). It was filled with
clear fluid and was negative for Nikolsky sign. There
were no mucosal lesions. Systemic examination was
otherwise unremarkable.Fig. 1 The figure shows a large, tense, non-erythematous bullous
lesion, measuring approximately 0.5 cm × 0.8 cm, seen on the
planter surface of the right foot near the interdigital cleftThe differential diagnosis based on this initial encoun-
ter included bullous scabies, bullous impetigo, frictional
bulla and bullous pemphigoid.
Scrapings were taken from the maculopapular lesions
on the hands and the bulla on the foot; direct micros-
copy, prepared from 10 % potassium hydroxide (KOH),
revealed mites and eggs of Sarcoptes Scabiei in scrapings
from both the points. Direct swabs from the hand le-
sions and the bulla did not show any bacterial or fungal
growth upon culture.
Based on the history, examination and investigations’
findings, the final diagnosis of bullous scabies was made.
The patient was treated with whole body applications
of 5 % topical permethrin and local application of anti-
histamine lotion. Complete remission of the lesions was
noted after 3 weeks. The patient remained disease free
for upto 18 months of follow-up.
Discussion
Bullous scabies usually occurs in the elderly population.
The cases that we came across during our review
had a predominantly male predilection (21 out of 30
were males). Out of the 32 cases reviewed, most (21
out of 32) of the patients were older than 60 years.
It usually presents as intensely pruritic bullae, which
may be tense or flaccid and at times may have asso-
ciated hemorrhage. They are usually present in sca-
bies prone areas and may or may not have associated
classic scabietic lesions [9].
The pathogenesis of bullae formation in scabies is not
entirely clear and a number of theories have been pro-
posed to explain their pathogenesis. Staphylococcus
Aureus superinfection of mite lesions is one mechanism
that can result in vesicle formation; this is similar to the
bullae formation in bullous impetigo [9]. The second
mechanism that has been proposed is autoantibody
mediated immune damage leading to bulla formation.
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production of these antibodies. According to one hy-
pothesis, antibodies could be produced due to lytic de-
struction of the basement membrane by mites’ enzymes
(leading to antigenic changes) [10]. The result of these
changes is the production of BP-like antigens. These
antigens will elicit BP antibodies that activate the
compliment cascade, and attract eosinophils and lym-
phocytes; subsequent secretion of protease enzymes
leads to dermoepidermal separation [10]. The presence
of mites within the intraepidermal blisters further
strengthens the theory that mite enzymes have a role in
the pathogenesis of bullae formation [11].
Another theory suggests that the mite may elicit anti-
bodies that cross-react with the basement membrane
zone (BMZ) antigens (antigen mimicry) [10]; these anti-
bodies (BP antibodies) act like those present in true
autoimmune diseases, resulting in autoimmune damage
[12]. We therefore have reason to expect antibodies to
the BP antigens to be positive, as demonstrated in some
cases in the literature; in one previous Western blot
study, circulating antibodies against BP180 and/or BP
230 were found in the sera of two scabetic patients with
bullous eruptions [13]. It also shows that at least some
bullous eruptions in scabies patients are true bullous
pemphigoid lesions. There are various possibilities in
such cases; while the two diseases may occur simultan-
eously in a patient independently from each other, often-
times the scabies is thought to trigger the characteristic
bullous eruptions of bullous pemphigoid via a Koebner
phenomenon. This is especially of relevance in those
cases where the bullae are located exclusively on the
body sites where there are scabietic lesions present as
well. Moreover, in these patients where bullae appear
solely on the sites affected by scabies, a possible ex-
planation for the bullous eruptions can also be a
Type 1 immune response to an antigen from the sal-
iva of Sarcoptes Scabiei; it has been reported that the
occurrence of bullous allergic hypersensitivity reac-
tions to bug bites mediated by immunoglobulin E
against compounds in the saliva of the biting insect
is possible [14]. Our patient did not have any circu-
lating antibody test, so we cannot comment regarding
this aspect–pathogenesis–of bullous scabies in relation
to our patient.
On direct immunofluorescence, complement compo-
nent 3 (C3) and Immunoglobulin G deposition is often
seen in bullous scabies. Out of the 25 cases in which
direct immunoflouresence was performed, 9 had IgG
deposition and C3 deposition was present in 13 cases.
The pattern of IgG deposition was linear in 8 cases and
granular in 3; the 2 cases reported by Brawan, et al. [15]
showed both granular as well as linear IgG deposition in
the basement membrane zone.The various signs that have been used to confirm the
diagnosis of bullous scabies include bullous eruptions
over sites of the body that are usually prone to scabies,
involvement of genital organs, nocturnal itch, improve-
ment after application of antiscabietic medications and
detection of the scabies mite on histopathology sections
of lesions [1].
Bullous scabies is usually treated in the same way as
the classical form of scabies [1]. According to The Loss
Angeles County Department of Public Health Acute
Communicable Disease Program, the recommended
medications for scabies are 5 % permethrin cream, 10 %
crotamiton lotion/cream and ivermectin [16]. Other
antiscabietic agents that are employed are benzyl benzo-
ate, malathion, and 6 % sulfur ointment [4].
In some cases of bullous scabies, a short course of oral
steroids may also be required [17]. In more serious cases
or in cases of steroid intolerance, other immunosuppres-
sive agents, such as methotrexate, azathioprine, myco-
phenolate mofetil and cyclosporine, can be employed
[4]. These may also be used as adjunct therapy. Al-
though the mechanism of formation of bullae in bullous
scabies is immune mediated, it is hard to explain why
cases have been reported in which bullous scabies failed
to respond to glucocorticoid, immunoglobulin and
cyclophosphamide therapy [8].
Out of the 32 cases reported so far, 8 patients were
treated with gamma benzene hexachloride, 7 with benzyl
benzoate, 5 with permethrin, and 3 with oral ivermectin;
combinations of permethrin with oral ivermectin, oral
and topical steroids, gamma benzene hexachloride or
sulfur were also used in some cases [1,4,8].
Conclusion
It is suggested that the diagnosis of scabies be consid-
ered in all patients who present with tense bullous
lesions accompanied by pruritis and a papular rash. This
is particularly relevant if these lesions do not resolve
with steroid treatment. Suspecting scabies in such pa-
tients is therefore of paramount importance, as it may
not only co-exist with bullous pemphigoid, but is also an
important possible precipitant for this condition. In such
patients, consequently, it is important to test the lesions
for Sarcoptes Scabiei mites and eggs.
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